Implementation of Double Immune Checkpoint Blockade Increases Response Rate to Induction Chemotherapy in Head and Neck Cancer.

MLA

Semrau, Sabine, et al. “Implementation of Double Immune Checkpoint Blockade Increases Response Rate to Induction Chemotherapy in Head and Neck Cancer.” Cancers, vol. 13, no. 8, Apr. 2021, p. 1959. EBSCOhost, https://doi.org/10.3390/cancers13081959.

APA

Semrau, S., Gostian, A.-O., Traxdorf, M., Eckstein, M., Rutzner, S., von der Grün, J., Illmer, T., Hautmann, M., Klautke, G., Laban, S., Brunner, T., Tamaskovics, B., Frey, B., Zhou, J.-G., Geppert, C.-I., Hartmann, A., Balermpas, P., Budach, W., Gaipl, U., & Iro, H. (2021). Implementation of Double Immune Checkpoint Blockade Increases Response Rate to Induction Chemotherapy in Head and Neck Cancer. Cancers, 13(8), 1959. https://doi.org/10.3390/cancers13081959

Chicago

Semrau, Sabine, Antoniu-Oreste Gostian, Maximilian Traxdorf, Markus Eckstein, Sandra Rutzner, Jens von der Grün, Thomas Illmer, et al. 2021. “Implementation of Double Immune Checkpoint Blockade Increases Response Rate to Induction Chemotherapy in Head and Neck Cancer.” Cancers 13 (8): 1959. doi:10.3390/cancers13081959.